Drugs / AntiCov-220
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05043324 | Feb 2020 → Apr 2022 | COVID-19 | Nguyen Thi Trieu, MD | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AntiCov-220 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05043324 ↗ |